Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Eylea
Eylea
Regeneron's Eylea combination therapy fails mid-stage study
Yahoo/Reuters
Fri, 09/30/16 - 09:45 am
Regeneron
Eylea
clinical trials
wet age-related macular degeneration
Bayer raises sales targets for top-selling drugs after Monsanto deal
Yahoo/Reuters
Tue, 09/20/16 - 09:53 am
Bayer
Monsanto
M&A
Xarelto
Eylea
Eylea sales lift Regeneron's profit past estimates
Yahoo/Reuters
Thu, 08/4/16 - 10:01 am
Regeneron
earnings
Eylea
Bayer hikes guidance as its pharma darlings Xarelto, Eylea power better-than-expected sales growth
Fierce Pharma
Wed, 07/27/16 - 03:06 pm
Bayer
earnings
Eylea
Xarelto
9 Drugs That Cost Medicare a Fortune
Motley Fool
Sun, 04/10/16 - 01:29 pm
Medicare
Lucentis
Eylea
Prolia
Treanda
Lexiscan
Yervoy
Privigen
Provenge
Soliris
Regeneron Eye Drug's Advantage Over Roche's Narrowed in Trial
Bloomberg
Sun, 02/28/16 - 10:52 am
Regeneron
dry eye disease
Roche
Lucentis
Eylea
FDA sets LixiLan decision date for Sanofi-Novo diabetes showdown; Eylea could outshine Bayer's sales forecasts, analyst predicts
Fierce Pharma
Mon, 02/22/16 - 06:08 pm
FDA
LixiLan
Sanofi
Novo Nordisk
Bayer
Eylea
Regeneron: It’s the Eylea Outlook That Matters
Barron's
Mon, 02/8/16 - 12:46 pm
Regeneron
Eylea
Will 2016 Be Regeneron Pharmaceuticals Inc.'s Best Year Yet?
Motley Fool
Wed, 01/6/16 - 03:11 pm
Regeneron
Praluent
Eylea
Regeneron Tests Buy Point As New Drug Shows Promise
Investors.com
Sat, 11/14/15 - 11:22 am
Regeneron
Eylea
Sanofi
Regeneron Pharmaceuticals Inc (REGN) Stock Update: Praluent And Eylea Drive Future Growth
Bidness, ETC
Wed, 09/23/15 - 09:49 am
Regeneron
Praluent
Eylea
The Next Blockbusters Could Be Balms For Aging Eyes
Investors.com
Thu, 09/3/15 - 09:10 am
age-related macular degeneration
Bayer
Regeneron
Ophthotech
Allergan
Novartis
Applied Genetic Technologies
Avalanche Biotechnologies
Roche
Lucentis
Eylea
Eylea erodes Lucentis, Avastin market share
Medical Marketing and Media
Tue, 08/4/15 - 06:10 pm
Eylea
Lucentis
Avastin
Regeneron
Roche/Genentech
What Is Beyond Vision-Loss Blockbuster For Regeneron?
Investors.com
Wed, 07/1/15 - 10:49 pm
Regeneron
Eylea
Praluent
Roche, Novartis and Bayer snag NICE OKs
Fierce Pharma
Tue, 06/2/15 - 04:50 pm
NICE
Roche
Novartis
Bayer
Gazyvaro
Cosentyx
Eylea
Regeneron expects Eylea sales to rise 30-35 pct this year
Yahoo/Reuters
Thu, 05/7/15 - 09:15 am
Regeneron
Eylea
FDA again expands usage of Regeneron eye drug Eylea
Yahoo/Reuters
Thu, 03/26/15 - 07:49 am
Eylea
Regeneron
FDA
Bayer nabs new Eylea nod to help it toward 2015 sales target
Fierce Pharma
Fri, 02/27/15 - 06:59 pm
Bayer
Europe
Eylea
retinal vein occlusion
Bayer feels sting of mixed decision from NICE for Eylea's use in diabetics
Fierce Pharma
Fri, 02/20/15 - 05:41 pm
Bayer
NICE
Eylea
Regeneron Beats Genentech In Rare Face Off Over Diabetes-Related Vision Loss
Forbes
Thu, 02/19/15 - 10:38 am
Regeneron
Genentech
diabetes
Eylea
Lucentis
DME
diabetic macular edema
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »